Compounds > efavirenz

efavirenz and Deficiency, Vitamin D

efavirenz has been researched along with Deficiency, Vitamin D in 14 studies

Research

Studies (14)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (7.14)29.6817
2010's12 (85.71)24.3611
2020's1 (7.14)2.80

Authors

AuthorsStudies
Durán, MV; Greco, D; Lopardo, G; Sabato, S; Sánchez Thomas, D1
Bopitiya, S; Das, S; Dhother, J; Taha, H1
Dewit, S; Sersté, T; Theodorou, M; Van Gossum, M1
Boven, K; Deckx, H; Doroana, M; Orkin, C; Pilotto, JH; Sungkanuparph, S; Vanveggel, S; Wohl, DA; Yeni, P1
Cardoso, SW; Coelho, L; Currier, JS; Grinsztejn, B; Hoffman, RM; Lake, JE; Luz, PM; Mendonça, L; Veloso, VG1
Avihingsanon, A; Avihingsanon, Y; Hiransuthikul, N; Kerr, SJ; Khovidhunkit, W; Praditpornsilpa, K; Ramautarsing, RA; Ruxrungtham, K; Sophonphan, J; Ubolyam, S1
Aklillu, E; Bertilsson, L; Burhenne, J; Diczfalusy, U; Habtewold, A; Makonnen, E; Nylén, H; Yimer, G1
Brown, TT; McComsey, GA1
Childs, K; Ibrahim, F; Moniz, CF; Post, FA; Poulton, M; Taylor, CB; Welz, T1
Ajana, F; Cortet, B; de la Tribonniere, X; Dubus, S; Legroux-Gérot, I; Melliez, H; Paccou, J; Pasquet, A; Viget, N; Yazdanpanah, Y1
Baumann, S; Furrer, H; Fux, CA; Mueller, NJ1
Abdollahi, A; Dashti-Khavidaki, S; Etminani-Esfahani, M; Jafari, S; Khalili, H1
Allavena, C; Bernard, J; Billaud, E; Cuzin, L; Delpierre, C; Duvivier, C; Guillot, P; Raffi, F; Rey, D; Viget, N1
Gyllensten, K; Josephson, F; Lidman, K; Sääf, M1

Trials

3 trial(s) available for efavirenz and Deficiency, Vitamin D

ArticleYear
Change in vitamin D levels and risk of severe vitamin D deficiency over 48 weeks among HIV-1-infected, treatment-naive adults receiving rilpivirine or efavirenz in a Phase III trial (ECHO).
    Antiviral therapy, 2014, Volume: 19, Issue:2

    Topics: Adolescent; Adult; Aged; Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Double-Blind Method; Female; HIV Infections; HIV-1; Humans; Male; Middle Aged; Nitriles; Pyrimidines; Rilpivirine; Risk Factors; Vitamin D; Vitamin D Deficiency; Young Adult

2014
Vitamin D3 supplementation in HIV infection: effectiveness and associations with antiretroviral therapy.
    Nutrition journal, 2015, Aug-18, Volume: 14

    Topics: Adult; Alkynes; Antiretroviral Therapy, Highly Active; Benzoxazines; Brazil; Cholecalciferol; Cyclopropanes; Dietary Supplements; Female; HIV Infections; Humans; Linear Models; Male; Middle Aged; Multivariate Analysis; Prospective Studies; Risk Factors; Socioeconomic Factors; Vitamin D Deficiency

2015
Effects of vitamin D supplementation on the bone specific biomarkers in HIV infected individuals under treatment with efavirenz.
    BMC research notes, 2012, Apr-26, Volume: 5

    Topics: Adult; Alkynes; Anti-HIV Agents; Benzoxazines; Biomarkers; Bone and Bones; Bone Remodeling; Cyclopropanes; Dietary Supplements; Female; HIV Infections; Humans; Iran; Male; Metalloendopeptidases; Middle Aged; Osteocalcin; Prevalence; Prospective Studies; Reverse Transcriptase Inhibitors; Treatment Outcome; Vitamin D; Vitamin D Deficiency; Vitamins

2012

Other Studies

11 other study(ies) available for efavirenz and Deficiency, Vitamin D

ArticleYear
[High prevalence of hypovitaminosis D in HIV-infected persons attending an outpatient clinic, Buenos Aires city].
    Medicina, 2019, Volume: 79, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Alkynes; Ambulatory Care Facilities; Antirheumatic Agents; Argentina; Benzoxazines; CD4 Lymphocyte Count; Cyclopropanes; Female; HIV Infections; Humans; Male; Middle Aged; Prevalence; Retrospective Studies; Reverse Transcriptase Inhibitors; Risk Factors; Viral Load; Vitamin D Deficiency; Young Adult

2019
The Effect of Low Dose Oral Vitamin D on Bone Mineral Density Changes in HIV Patients: 36 Months Follow Up.
    Infectious disorders drug targets, 2020, Volume: 20, Issue:5

    Topics: Adult; Alkynes; Anti-HIV Agents; Benzoxazines; Bone Density; Cyclopropanes; Female; Follow-Up Studies; HIV Infections; Humans; Male; Middle Aged; Parathyroid Hormone; Prospective Studies; Tenofovir; Vitamin D; Vitamin D Deficiency

2020
Factors associated with vitamin D deficiency in a population of 2044 HIV-infected patients.
    Clinical nutrition (Edinburgh, Scotland), 2014, Volume: 33, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Alkynes; Benzoxazines; CD4 Lymphocyte Count; Cyclopropanes; Female; HIV Infections; Humans; Male; Middle Aged; Prevalence; Retrospective Studies; Risk Factors; Viral Load; Vitamin D; Vitamin D Deficiency; Young Adult

2014
The Association of Gender, Age, Efavirenz Use, and Hypovitaminosis D Among HIV-Infected Adults Living in the Tropics.
    AIDS research and human retroviruses, 2016, Volume: 32, Issue:4

    Topics: Adult; Age Factors; Aged; Alkynes; Anti-HIV Agents; Benzoxazines; Cross-Sectional Studies; Cyclopropanes; Female; HIV Infections; Humans; Male; Middle Aged; Prevalence; Sex Factors; Thailand; Tropical Climate; Vitamin D Deficiency

2016
Prevalence and risk factors for efavirenz-based antiretroviral treatment-associated severe vitamin D deficiency: A prospective cohort study.
    Medicine, 2016, Volume: 95, Issue:34

    Topics: Adult; Alkynes; Antiretroviral Therapy, Highly Active; Antitubercular Agents; Benzoxazines; Cholesterol; Cohort Studies; Cyclopropanes; Ethiopia; Female; HIV Infections; Humans; Male; Prevalence; Prospective Studies; Rifampin; Risk Factors; Treatment Outcome; Tuberculosis, Pulmonary; Vitamin D; Vitamin D Deficiency

2016
Association between initiation of antiretroviral therapy with efavirenz and decreases in 25-hydroxyvitamin D.
    Antiviral therapy, 2010, Volume: 15, Issue:3

    Topics: Adolescent; Adult; Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Drug Therapy, Combination; HIV Infections; HIV-1; Humans; Middle Aged; Reverse Transcriptase Inhibitors; Treatment Outcome; Vitamin D; Vitamin D Deficiency; Young Adult

2010
Efavirenz is associated with severe vitamin D deficiency and increased alkaline phosphatase.
    AIDS (London, England), 2010, Jul-31, Volume: 24, Issue:12

    Topics: Adult; Alkaline Phosphatase; Alkynes; Antiretroviral Therapy, Highly Active; Benzoxazines; Bone Remodeling; CD4 Lymphocyte Count; Cross-Sectional Studies; Cyclopropanes; Female; HIV Infections; HIV-1; Humans; London; Male; Reverse Transcriptase Inhibitors; Vitamin D Deficiency

2010
Vitamin D deficiency in HIV-infected patients: associated with non-nucleoside reverse transcriptase inhibitor or efavirenz use?
    AIDS (London, England), 2011, Mar-27, Volume: 25, Issue:6

    Topics: Alkynes; Antiretroviral Therapy, Highly Active; Benzoxazines; Cyclopropanes; HIV Infections; HIV-1; Reverse Transcriptase Inhibitors; Vitamin D Deficiency

2011
Is lower serum 25-hydroxy vitamin D associated with efavirenz or the non-nucleoside reverse transcriptase inhibitor class?
    AIDS (London, England), 2011, Mar-27, Volume: 25, Issue:6

    Topics: Alkynes; Antiretroviral Therapy, Highly Active; Benzoxazines; Cyclopropanes; HIV Infections; HIV-1; Reverse Transcriptase Inhibitors; Vitamin D Deficiency

2011
High frequency of vitamin D deficiency in HIV-infected patients: effects of HIV-related factors and antiretroviral drugs.
    The Journal of antimicrobial chemotherapy, 2012, Volume: 67, Issue:9

    Topics: Adult; Alkynes; Anti-Retroviral Agents; Benzoxazines; Cohort Studies; Cross-Sectional Studies; Cyclopropanes; Female; France; HIV Infections; Humans; Male; Middle Aged; Prospective Studies; Vitamin D Deficiency

2012
Severe vitamin D deficiency diagnosed after introduction of antiretroviral therapy including efavirenz in a patient living at latitude 59 degrees N.
    AIDS (London, England), 2006, Sep-11, Volume: 20, Issue:14

    Topics: Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Cytochrome P-450 Enzyme Inhibitors; HIV Infections; Humans; Male; Oxazines; Vitamin D Deficiency

2006